Exclusive

Publication

Byline

Lilly acquires Kelonia Therapeutics for $7 B to advance in vivo CAR-T cell therapies

Singapore, April 21 -- US-based Eli Lilly and Company, and Kelonia Therapeutics, Inc., a US-based clinical-stage biotechnology company pioneering in vivo gene delivery, have announced a... Read More


Australia announces $14.6 M boost for allergy research, care and support

Singapore, April 20 -- The Australian government has committed a further $14.6 million to drive research, care and support for Australians affected by allergies.  The funding... Read More


Scientists in Singapore develop AI-powered biochip that detects genetic markers in 20 minutes

Singapore, April 20 -- A team of scientists from Nanyang Technological University (NTU) Singapore has developed a new biochip that, when paired with Artificial Intelligence (AI), can de... Read More


China's Pulnovo Medical secures strategic investment from Medtronic in oversubscribed $100 M financing round

Singapore, April 20 -- China-based Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, has announced the successful completion of an oversubscri... Read More


Freudenberg Medical launches ISO Class 5 controlled cleanroom for sterile single-use assemblies

Singapore, April 20 -- Germany-based Freudenberg Medical, a global contract design and manufacturing partner to the medical device and biopharma industry, has announced the launch of CleanAssure,... Read More


Korea's Seegene introduces STAgora highlighting real-time data with automated PCR workflows

Singapore, April 20 -- Seegene, a global molecular diagnostics company, has introduced STAgora™, a real-time data analytics platform based on aggregated statistical testing data, and presented a... Read More


Australian startup BlinkLab secures A$17.5 M for launch of autism diagnostic aid

Singapore, April 18 -- Australia based BlinkLab, a leading digital healthcare startup focused on the development of artificial intelligence (AI)-powered diagnostic technology, has successfully complet... Read More


Shionogi makes investment in Japanese startup Restore Vision to develop visual restoration gene therapy

Singapore, April 16 -- Shionogi & Co. has made an equity investment in Restore Vision Inc, a Tokyo-based startup company developing innovative technologies in the field of ophthalmology. This investme... Read More


Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel

Singapore, April 15 -- Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel. The launc... Read More


Taiwan's Senhwa Biosciences secures funding upto NT$500 M to accelerate AI-driven drug development

Singapore, April 14 -- Senhwa Biosciences, Inc., a Taiwan-based clinical-stage biopharmaceutical company, has announced the signing of a Memorandum of Understanding (MoU) with GEM YIELD BAHAMAS, an af... Read More